🇨🇦 Pf-06954522 in Canada

Pf-06954522 (pf-06954522) regulatory status in Canada.

Marketing authorisation

Pf-06954522 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Rare Disease approved in Canada

Frequently asked questions

Is Pf-06954522 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Pf-06954522 in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.